DSKYF - Merck Daiichi lung cancer therapy rejected in U.S.
2024-06-27 07:56:32 ET
More on Merck
- Merck & Co., Inc. (MRK) Goldman Sachs 45th Annual Global Healthcare Conference - (Transcript)
- Dividends And Innovation: Why Merck Is A Healthcare Stock Worth Buying
- Merck & Co., Inc. (MRK) Investor Event at ASCO 2024 (Transcript)
- Merck wins approval of RNA-based dog flu vaccine
- Merck gets FDA approval for Capvaxive pneumonia vaccine (update)